Pharma-Health Ministry talks hit impasse again? Foreign pharma companies continue to push for price rises outside the Health Ministry’s comfort zone, Al Borsa reports. According to an unnamed source, international manufacturers have rejected the MoH’s “30/30” proposal, which would have allowed a 30% annual rise in the prices of 30% of all products. The manufacturers said the proposal would fail to make them whole after the float of the EGP, demanding instead a 60% across-the-board price increase. Health Minister Ahmed Rady has refused the demand. Meanwhile, the House of Representatives’ Health Affairs Committee has backtracked on its initial refusal of price hikes and is investigating a number of potential solutions, committee head Magdi Morshed said.